May 7, 2020 – Executive search firm Slone Partners has placed Roger D. Klein as chief medical officer of OmniSeq. Dr. Klein will support OmniSeq in its continued development of innovative products that help oncologists identify the best precision medicine options for their patients. “Dr. Klein is a highly accomplished leader in the innovative fields of molecular pathology, oncology and precision medicine,” said Tara Kochis-Stach, president of Slone Partners. “He will be a tremendously valuable addition to OmniSeq’s executive team.”
“As our new clinical affairs leader, Dr. Klein will play a critical role in educating oncologists, pathologists and other clinicians on how to leverage molecular information to improve clinical decision-making and therapeutic selection for patients with advanced cancers,” said Margot Schoenborn, CEO of OmniSeq. “He brings insights into treating providers’ needs that will help drive our clinical evidence development initiatives.”
Executive Recruiters & Talent Leaders Navigate Uncertain Times
Hunt Scanlon’s latest executive recruiting industry sector report will be available in 30 days. This will be the most important search industry sector report that Hunt Scanlon has ever produced! The nation’s top executive recruiters are resetting expectations in the midst of an unprecedented global pandemic crisis. Many expect a significant pause in business, followed by a sharp rebound later this year. We talk to the experts, uncover the opportunities, pick the sectors and reveal how search firms and talent organizations are navigating and adapting in uncertain times. Healthcare, biotech, crisis response, supply chain & logistics and the vast private equity sector are all showing signs of strength – and a big need for talent.
Hear from top talent experts, including: Greenwood/Asher & Associates; August Leadership; Brainworks; The Loring Group; Signium; ChampionScott; SRi; Myers McRae; RM Nephew; Vetted Solutions; IIC Partners; The Lancer Group; Alexander Hughes; Furst Group; Tillman Partners; Young Search Partners; Ormsby Park; Frederickson Partners; 4D Executive Search; Kensington International; AMROP; Direct Recruiters; Berkhemer Clayton; Cognitive Talent Partners; ZurickDavis; Crossdale Paul; Beaumont Bailey & more!
Dr. Klein joins OmniSeq with nearly 30 years of experience in the medical industry and a distinguished career in molecular pathology. He previously held leadership roles in molecular pathology at the Cleveland Clinic, the BloodCenter of Wisconsin and the H. Lee Moffitt Cancer Center. Dr. Klein is a faculty fellow at the Center for Law, Science and Innovation at Arizona State University’s Sandra Day O’Connor Law School and serves as an expert with the Federalist Society’s Regulatory Transparency Project. He has also been an advisor to the Department of Health and Human Services, the Food and Drug Administration, the Centers for Medicare and Medicaid Services, and the Centers for Disease Control and Prevention. Dr. Klein received his undergraduate and medical degrees from Case Western Reserve University and completed post-graduate medical education at Yale University School of Medicine and the Mayo Clinic. In addition, he has a law degree from Yale Law School.
“I am thrilled to be joining OmniSeq at an exciting time for cancer diagnostics and precision medicine at a pivotal juncture for the company,” said Dr. Klein. “I look forward to working with OmniSeq’s outstanding and talented team and am dedicated to supporting the organization in its mission to advance precision medicine and improve patient outcomes.”
Slone Partners is a nationally recognized senior-level recruitment provider that specializes in delivering executive, management and leadership talent for the diagnostic, biopharmaceutical, healthcare information technology and laboratory testing industries. The firm has offices in Boston, New York, Washington, D.C. and San Francisco. Recently, Slone Partners was included among Hunt Scanlon Media’s “Top 50 Healthcare & Life Sciences Search Firms.”
Chief Medical Officers
According to recruiters, the role of the chief medical officer has evolved in recent years, and organizations are looking for leaders with broader skill-sets. “Today’s CMO needs to have professional experience gathered from different players in the drug development industry,” said Marc Salzberg, CEO of Airway Therapeutics. “He or she needs to understand the objectives of the key players in the field—academia / clinical practice, the pharma industry, regulatory authorities and third-party vendors, such as contract research organizations—in order to successfully cooperate with those partners.”
Over the past few months, numerous healthcare organizations have turned to executive search firms to find new CMOs. And in the era of COVID-19 we can expect this to be another burgeoning area for executive search firms.
Here is a sampling from the Hunt Scanlon Media archives:
COORS Leadership recently placed Trina D. Abla as chief medical officer of Mercy Catholic Medical Center in Pennsylvania. Dr. Abla most recently was chief quality officer and associate CMO at Penn State Health St. Joseph. Founded in 1999 by Cheryl Coors, COORS Leadership Capital is a retained, certified woman-owned small business specializing in consulting and executive search services.
Nationwide Children’s Hospital in Columbus, OH, tapped Cejka Search to lead its search for a new CMO. Paul Esselman, president and managing director at Cejka, is leading the assignment. Reporting to the CEO, the CMO has overall responsibility for the quality of patient care delivered throughout Children’s Hospital and its subsidiaries, said Cejka Executive Search.
Contributed by Scott A. Scanlon, Editor-in-Chief; Dale M. Zupsansky, Managing Editor; and Stephen Sawicki, Managing Editor – Hunt Scanlon Media